Arsenal Capital Partners has completed a strategic investment in OncoHealth, according to a news release.

OncoHealth, based in Atlanta, is a digital health company that combines data and analytics with oncology experts to provide solutions used by health plans, employers, providers, patients and life sciences researchers to help navigate the physical, mental and financial complexities of cancer.

Arsenal, based in New York, is a private equity firm specializing in investments in middle market healthcare and specialty industrials companies. Founded in 2000, the firm seeks control investments in companies with the capacity to use $50 million to $300 million of equity, including add-on acquisitions.

It was also announced that McKesson Corp. invested in OncoHealth.

Terms of the investments were not disclosed.

RoundTable Healthcare Partners has announced the closing of its sixth private equity fund with $800 million in capital commitments.

The firm closed its previous fund in 2019 with $700 million.

RoundTable, based in Lake Forest, Ill., is an operating-oriented private equity firm focused exclusively on the healthcare industry. Founded in 2001, the firm targets middle market investments in medical devices, medical products and disposables; specialty pharmaceuticals; medication delivery systems; specialty distribution; and complementary outsourced services.

McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their careers in private equity in a way that best challenges and motivates them, which these impressive women have all done. We are pleased to feature Caroline Stevens of MPK Equity Partners. Access her profile.

To recommend a woman for a future interview, email Amber Walsh at

Avista Capital Partners has announced it has closed on the sale of Inform Diagnostics to Fulgent Genetics for approximately $170 million.

Inform Diagnostics, based in Irving, Texas, is an independent pathology laboratory business that has laboratories in Irving, Texas, as well as Boston, New York City and Phoenix.

Fulgent Genetics (NASDAQ: FLGT), based in Temple City, Calif., is a technology-based genetic testing company. Fulgent performs full-gene sequencing with deletion/duplication analysis in an array of panels.

Avista, based in New York, makes control buyout investments in middle market healthcare companies. Founded in 2005, the firm focuses on the following healthcare subsectors: pharmaceuticals, medical devices, outsourced pharmaceutical services, distribution and consumer-driven healthcare.

KKR has announced it has closed its newest fund, KKR North America Fund XIII, with $19 billion.

The fund, which will focus on pursuing private equity investments in North America, was oversubscribed.

The private equity platform of Kohlberg Kravis Roberts (KKR) & Co., which is based in New York, considers investments in all industries, including healthcare. Founded in 1976, the firm prefers to invest in a range of debt and public equity investing and may co-invest, seeking a controlling ownership of a company or a strategic minority position.

TPG Capital has agreed to acquire ClaimsXten, Change Healthcare’s claims editing business, from UnitedHealth for $2.2 billion, according to news reports.

The sale of ClaimsXten will only proceed if UnitedHealth’s acquisition of Change Healthcare is completed. The acquisition is currently on hold after the U.S. Department of Justice sued to stop the deal.

Previous reports indicated that UnitedHealth was hoping the sale of ClaimsXten would help secure federal approval for its $8 billion acquisition of Change Healthcare.

TPG Capital, headquartered in Fort Worth, Texas and San Francisco, targets investments in middle-market companies in healthcare and a number of other industries.

Clayton, Dubilier & Rice (CD&R) will acquire the hospice and personal care divisions of Humana’s Kindred at Home (KAH) subsidiary for about $2.8 billion, according to a news release.

The transacted divisions include patient-centered services for hospice, palliative, community and personal care.

The deal is expected to close in the third quarter.

CD&R, with its U.S. office in New York, is a private equity firm that pursues investments in healthcare and a few other sectors. Founded in 1978, the firm states it has managed the investment of approximately $40 billion in more than 100 companies.

Enhanced Healthcare Partners (EHP) has announced it has completed a strategic growth investment in Vytalize Health.

Vytalize, based in Hoboken, N.J., is a value-based care platform for seniors. The company’s vertically integrated solution combines a risk-bearing entity, virtual and in-home clinic model, and technology platform. Vytalize states that it supports physicians caring for more than 130,000 senior patients. The company announced that it had closed over $50 million in Series B financing led by EHP.

EHP, with offices in New York and Salt Lake City, Utah, is a healthcare-focused private equity firm that makes minority and majority investments in founder- and entrepreneur-led lower middle market companies. Founded in 2005, the firm seeks to invest in companies between $50 million and $250 million in enterprise value.

Terms of the transaction were not disclosed.

FFL Partners has announced it has invested in Perlman Clinic.

Perlman, based in San Diego, is an independent provider of primary care in the Greater San Diego Market. Founded in 2005, Perlman operates 16 facilities staffed by more than 100 primary care providers who provide primary care, urgent care, behavioral health and wellness services.

FFL Partners, based in San Francisco, invests in middle market companies within healthcare and business services. Founded in 1997, the firm generally commits $50 million to $200 million to individual transactions.

Terms of the transaction were not disclosed.

One Equity Partners (OEP) has announced the closing of its newest fund, One Equity Partners VIII, with committed capital of $2.75 billion.

Through the fund, OEP will continue to target equity investments between $30 million and $300 million in healthcare and a few other types of businesses across North America and Europe.

OEP, based in New York, is a middle market private equity firm. Founded in 2001 and spun out of J.P. Morgan in 2015, OEP seeks control-oriented investments with flexible structure in companies with revenue between $100 million and $800 million and EBITDA of $10 million to $70 million.